Geneva: The World Health Organization said Thursday that each Covid-19 vaccine was authorized for emergency use must be recognized by countries when they open their borders for inoculated tourists.
This step can challenge Western countries to expand their acceptance of two Chinese vaccines that appear to be less effective, which has been licensed by the UN health agency but most European and North American countries have not.
In addition to vaccines by Pfizer-Biontech, Moderna Inc.
Astrazeneca and Johnson & Johnson, who also have given green light to two Chinese Jabs, made by Sinovac and Sinopharm.
In its aim to restore trips throughout Europe, the European Union said in May it would only recognize people like being vaccinated if they have received a shot that is licensed by the European Medicine Agency – although it is up to each country if they want to serve travelers who have it receive Other vaccines, including Sputnik V.
Russian Regulators of the EU drug are currently considering the China Sinovac vaccine license, but there is no time line on a decision.
It also does not recognize the version of AstraZeneca vaccine made in India, effectively traveling traveling for people in developing countries that receive doses through initiatives that have not been supported as Covax.
“Every size that only allows people to be protected by a subset of the WHO approved vaccine to benefit from the reopening of the trip …
will effectively create a two-level system, the more expanding the global vaccine for and worsening the inequality we have seen the distribution of Covid-19 vaccine , “said who said Thursday.
“It will have a negative impact on the economic growth that suffer most.” WHO says such movements damage “trust in soul-saving vaccines that have proven safe and effective.” In its review of two Chinese vaccines, the UN health agency said they were found significantly reducing the risk of hospitalization and death.
Two Chinese shots “inactive” vaccines, made with coronavirus were killed, while Western-made shots were made with newer technology which instead targeted the “surge” protein lining the surface of the coronavirus.
Although Western countries mostly rely on vaccines made in the US and Europe, such as Pfizer-Bontech and AstraZeneca, many developing countries have used Chinese-made shots.
Earlier this year, Head of China China’s Control and Prevention Center recognized the effectiveness of its low-growing shots.
Many countries have used millions of doses of two Chinese shots, including Seychelles and Bahrain, have seen a surge in Covid-19 even with a relatively high immunization rate.